Adult Onset Still’s Disease: Early Diagnosis and Treatment Increases Likelihood of Recovery
A case reminding physicians that rare conditions should be kept in the differential diagnosis of unusual presentations.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Adult Onset Still’s Disease (AOSD) is a rare systemic inflammatory disorder characterized by the following triad of signs and symptoms: persistent fevers, joint pain and a transient, salmon-colored rash. The cause of the disease is unknown, but it is thought to be an autoinflammatory disorder triggered by infectious agents. AOSD may share similar very high levels of ferritin as encountered in hemophagocytic lymphohistiocytosis (HLH) — a rare but possibly fatal disease presenting with overactive histiocytes and lymphocytes.
This unique case report, recently published in Case Reports in Medicine, highlights a patient who presents with symptoms of these two rare diseases.
Two months after moving from Asia to the United States, a 28-year-old woman developed pain and stiffness in the metacarpophalangeal and proximal interphalangeal joints of both hands. Her medical history was unremarkable, and she was taking no prescription or over-the-counter drugs. An erythematous skin rash quickly followed her joint pain, spreading over her entire body.
She was diagnosed with an allergy at an outpatient clinic and received oral antihistamines, but with no improvement. In fact, the patient continued to worsen and developed additional symptoms of dyspnea, chills, fever and cough. She was admitted to an outside hospital for respiratory failure. After 14 days, she was transferred to Cleveland Clinic.
Upon arrival, the patient was febrile, hypotensive and had a diffuse scaly rash, periorbital edema and icterus. Laboratory data revealed anemia, leukocytosis, thrombocytopenia, elevated liver enzymes, hypertriglyceridemia, increased interleukin-2 receptor levels and very high ferritin levels.
Bone marrow biopsy showed hemophagocytosis, and skin biopsy was suggestive of Still’s disease.
Upon diagnosis, the patient immediately began treatment with daily doses of methylprednisolone. The fever lessened and the rash improved. Due to these improvements, the dose of methylprednisolone was reduced. However, shortly after reducing the dose of steroids, the patient developed a high fever of 40.5°C and increased shortness of breath. The patient was transferred to the ICU, intubated and given anakinra (an IL-2 receptor antagonist) along with prednisone. The patient’s symptoms drastically improved. She was discharged six days later on cyclosporine and a gradual prednisone taper.
This patient case highlights the overlapping symptomatology and pathogenesis of AOSD and HLH that can make diagnosis complicated. Given the potentially fatal course of HLH, early identification and treatment are crucial to providing patients with either disease a positive outcome. This case also reminds us that rare conditions should be kept in the differential diagnosis of unusual presentations.
Dr. Brateanu is staff in the Department of Internal Medicine.